Researchers report that a protein called granzyme K is involved in age-related damage across multiple organs. The work, led by Monash University scientists and published in Immunity, connects granzyme K with signs of aging in the heart, liver and kidneys, pointing to a possible new target for therapies aimed at healthier aging.

Nature also highlights the finding as a way to explain aging effects without triggering inflammation. In its coverage of the same line of research, Nature describes experiments using aged mice engineered to lack granzyme K, reporting improved heart and liver function alongside reduced kidney damage. Across the outlets, the shared focus is on how disabling granzyme K may lessen age-associated organ harm, while the emphasis differs slightly: Medical Xpress stresses the broader organ-damage pathway and treatment prospects, while Nature underscores the “without inflammation” framing and the engineered-mouse results.